PFG
48
3
BF.B
53
3
SYF
69
5
ROP
56
2
UNP
40
4
ZION
65
4
NTRS
62
2
MAC
51
3
GLW
55
2
OXY
40
2
HOG
39
4
CMI
54
3
UHS
64
2
CMCSA
45
3
HCA
64
4
MSI
44
-14
XYL
52
5
GOOG
75
6
TROW
35
6
ED
37
-6
PFG
48
3
BF.B
53
3
SYF
69
5
ROP
56
2
UNP
40
4
ZION
65
4
NTRS
62
2
MAC
51
3
GLW
55
2
OXY
40
2
HOG
39
4
CMI
54
3
UHS
64
2
CMCSA
45
3
HCA
64
4
MSI
44
-14
XYL
52
5
GOOG
75
6
TROW
35
6
ED
37
-6
Financhill
Back

Chugai Pharmaceutical 10K Form

Buy
68

CHGCY
Chugai Pharmaceutical

Last Price:
$29.81
Seasonality Move:
11.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.7B
Cash Flow: $289.3M
Price / Cash Flow: 50.08
Annual Sales: $3.87
Price / Book: 7.7

Profitability

EPS (TTM): 0.75170
Net Income (TTM): $2.5B
Gross Margin: $5.5B
Return on Equity: 21.98%
Return on Assets: 18.88%

Chugai Pharmaceutical Earnings Forecast

Key Chugai Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 22 years for CHGCY is 71.01%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 9.41% of Gross Profit Margin.
  • The Research & Development expenses have been 15.50% of Revenue.
  • The Interest Expense is 0.01% of Operating Income.
  • The Net Earning history of CHGCY is 33.09% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 14 years.

Chugai Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 7.28
Quick Ratio: 5.95

Price-to-Earnings

Trailing P/E Ratio: 38.32
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Buy
68
Chugai Pharmaceutical (CHGCY) is a Buy

Is Chugai Pharmaceutical a Buy or a Sell?